Sutent (sunitinib malate) has received a European Association of Urology recommendation, as first-line therapy in patients with metastatic renal cell carcinoma of good and intermediate risk, just two months after gaining EU marketing authorization for first line use in all patients with advanced and/or metastatic renal cell carcinoma.
Many Australian adults are enjoying improved oral health, but some are still missing out, according to a report by the Australian Institute of Health and Welfare (AIHW) launched by the Hon Tony Abbott at the 32nd Australian Dental Congress in Sydney.
Today, during the 85th General Session of the International Association for Dental Research, Forsyth Institute scientists are reporting that they have developed an effective program for eliminating cavities.
Many people, including health care workers, believe that morphine is a lethal drug that causes death when used to control pain for a patient who is dying. That is a misconception according to new research published in the latest issue of Palliative Medicine, from SAGE Publications.
Firefighters engage in a dangerous occupation, risking life-threatening burns and smoke inhalation, among other hazards. So it may surprise some that the leading cause of death on duty among U.S. firefighters is coronary heart disease (CHD).
The U.S. Food and Drug Administration (FDA) announced new draft guidance that would implement a more stringent approach for considering potential conflicts of interest for its advisory committee members and for recommending eligibility for meeting participation. FDA is accepting public comments on the proposal for the next 60 days.
Eating a high-fat diet may lead to an increased risk of invasive breast cancer in postmenopausal women.
New contracts for consultants and GPs are not to blame for NHS debts, says the BMA in its response to the Public Accounts Committee (PAC) report on financial management in the NHS.
Patients with arterial disease have relatively high rates of experiencing a cardiovascular event (such as heart attack, stroke or cardiovascular death) within one year, and these increase with the number of arterial locations afflicted, according to a large, international study in the March 21 issue of JAMA.
Survivors of acute lymphoblastic leukemia have a significantly increased risk of secondary cancers developing over 30 years after leukemia treatment when compared to the general population, according to a study in the March 21 issue of JAMA.